Weiyue Lu
Impact in
- Biomaterials top 0.05%
- Nanoparticle-Based Drug Delivery
- Microbiology top 0.2%
- Antimicrobial Peptides and Activities
Papers in
-
- RNA Interference and Gene Delivery 85
- Advanced biosensing and bioanalysis techniques 37
- Biomaterials 86
- Nanoparticle-Based Drug Delivery 83
- Co-authors
- Changyou Zhan (67 shared papers)Cao Xie (78 shared papers)Xiaoli Wei (32 shared papers)Gang Wei (37 shared papers)Ying Man (24 shared papers)Marzena Pazgier (10 shared papers)Yu Liu (18 shared papers)Bing Gu (11 shared papers)
- Journals
- Journal of Controlled Release (33 papers)International Journal of Pharmaceutics (15 papers)Molecular Pharmaceutics (12 papers)Acta Pharmaceutica Sinica B (11 papers)ACS Applied Materials & Interfaces (9 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Weiyue Lu
244 papers receiving 13.0k citations
Peers
Comparison fields: 5 of 149
- Biomaterials 4.9k
- Microbiology 1.3k
- Pharmaceutical Science 1.3k
- Molecular Biology 6.5k
- Biomedical Engineering 4.2k
Countries citing papers authored by Weiyue Lu
This map shows the geographic impact of Weiyue Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyue Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyue Lu more than expected).
Fields of papers citing papers by Weiyue Lu
This network shows the impact of papers produced by Weiyue Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyue Lu. The network helps show where Weiyue Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiyue Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 246 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 448 | |
| 2 | 2010 | 340 | |
| 3 | 2019 | 319 | |
| 4 | 2019 | 287 | |
| 5 | 2018 | 275 | |
| 6 | 2013 | 267 | |
| 7 | 2017 | 220 | |
| 8 | 2010 | 205 | |
| 9 | 2019 | 200 | |
| 10 | 2010 | 195 | |
| 11 | 2016 | 193 | |
| 12 | 2014 | 179 | |
| 13 | 2011 | 174 | |
| 14 | 2015 | 162 | |
| 15 | 2012 | 147 | |
| 16 | 2015 | 142 | |
| 17 | 2015 | 139 | |
| 18 | 2009 | 136 | |
| 19 | 2011 | 133 | |
| 20 | 2018 | 133 |
About Weiyue Lu
Weiyue Lu is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Pharmaceutical Science and Oncology, having authored 246 papers that have together received 13.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (85 papers), Nanoparticle-Based Drug Delivery (83 papers), Nanoplatforms for cancer theranostics (46 papers), Advanced biosensing and bioanalysis techniques (37 papers), Advanced Drug Delivery Systems (28 papers), Antimicrobial Peptides and Activities (14 papers), Immunotherapy and Immune Responses (13 papers) and Virus-based gene therapy research (12 papers). The work is most often cited by research in Biomaterials (4.9k citations), Microbiology (1.3k citations), Pharmaceutical Science (1.3k citations), Molecular Biology (6.5k citations) and Biomedical Engineering (4.2k citations). Weiyue Lu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Changyou Zhan, Cao Xie, Xiaoli Wei, Gang Wei, Ying Man, Marzena Pazgier, Yu Liu, Bing Gu, J. Łubkowski and Ronnie H. Fang. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics, Molecular Pharmaceutics, Acta Pharmaceutica Sinica B and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.